China’s Breakthrough in Breast Cancer Treatment | Shanghai Leads Global Innovation
Автор: The Everything Channel
Загружено: 2025-11-29
Просмотров: 0
A new era in cancer treatment is emerging from Shanghai.
In this video, explore how Fudan University Shanghai Cancer Center is leading groundbreaking research on a new HER2-targeting breast cancer drug, TQB2102, that has shown remarkable remission rates in its phase-II clinical trial. Learn about how this homegrown innovation could change the future of breast cancer therapy and boost China’s influence in global medical research.
Discover what makes this treatment unique, why international experts are watching closely, and how the journey from lab to life-changing therapy unfolds.
Keywords: China tech innovation, breast cancer research, HER2-positive therapy, Fudan University, Shanghai medical breakthrough, oncology news, neoadjuvant therapy, clinical trials in China, healthcare innovation, Dr Shao Zhimin.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: